Microbiological insights into respiratory infections and the opportunities for inhaled therapy

Kenneth Deans Bruce, Geraint Berian Rogers, Nilesh Patel

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)

Abstract

Respiratory infections represent the fourth most common cause of all deaths across age groups and countries. Treating these infections appropriately is a clear clinical priority and here we outline the types of therapy that are in current use for some of these infections. It is important that treatments are further improved and the potential of inhaled delivery to fulfil this need is considered. We describe novel methodologies that are being applied for the identification and enumeration of microorganisms in the respiratory tract, and propose that ways of improving therapy may arise from understanding better the etiology of respiratory infection and the impact of inhaled drug therapies. The potential for translational benefits for patients are also discussed.

Original languageEnglish
Pages (from-to)301-309
Number of pages9
JournalJOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
Volume21
Issue number4
DOIs
Publication statusPublished - 2011
Externally publishedYes

Keywords

  • Cystic fibrosis
  • COPD
  • Pneumonia
  • Tuberculosis

Fingerprint

Dive into the research topics of 'Microbiological insights into respiratory infections and the opportunities for inhaled therapy'. Together they form a unique fingerprint.

Cite this